1. Home
  2. FGEN vs MTC Comparison

FGEN vs MTC Comparison

Compare FGEN & MTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FGEN
  • MTC
  • Stock Information
  • Founded
  • FGEN 1993
  • MTC 2015
  • Country
  • FGEN United States
  • MTC Hong Kong
  • Employees
  • FGEN N/A
  • MTC N/A
  • Industry
  • FGEN Biotechnology: Pharmaceutical Preparations
  • MTC Computer Software: Prepackaged Software
  • Sector
  • FGEN Health Care
  • MTC Technology
  • Exchange
  • FGEN Nasdaq
  • MTC Nasdaq
  • Market Cap
  • FGEN 33.5M
  • MTC 36.3M
  • IPO Year
  • FGEN 2014
  • MTC 2019
  • Fundamental
  • Price
  • FGEN $0.30
  • MTC $0.89
  • Analyst Decision
  • FGEN Strong Buy
  • MTC
  • Analyst Count
  • FGEN 1
  • MTC 0
  • Target Price
  • FGEN $10.00
  • MTC N/A
  • AVG Volume (30 Days)
  • FGEN 1.6M
  • MTC 110.1K
  • Earning Date
  • FGEN 03-17-2025
  • MTC 04-08-2025
  • Dividend Yield
  • FGEN N/A
  • MTC N/A
  • EPS Growth
  • FGEN N/A
  • MTC N/A
  • EPS
  • FGEN N/A
  • MTC 1.16
  • Revenue
  • FGEN $29,621,000.00
  • MTC N/A
  • Revenue This Year
  • FGEN $472.13
  • MTC N/A
  • Revenue Next Year
  • FGEN $7.13
  • MTC N/A
  • P/E Ratio
  • FGEN N/A
  • MTC $0.83
  • Revenue Growth
  • FGEN N/A
  • MTC N/A
  • 52 Week Low
  • FGEN $0.18
  • MTC $0.18
  • 52 Week High
  • FGEN $2.40
  • MTC $12.90
  • Technical
  • Relative Strength Index (RSI)
  • FGEN 38.86
  • MTC 32.47
  • Support Level
  • FGEN $0.30
  • MTC $0.82
  • Resistance Level
  • FGEN $0.38
  • MTC $1.15
  • Average True Range (ATR)
  • FGEN 0.05
  • MTC 0.09
  • MACD
  • FGEN -0.00
  • MTC -0.01
  • Stochastic Oscillator
  • FGEN 16.30
  • MTC 9.61

About FGEN FibroGen Inc

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.

About MTC MMTec Inc.

MMTEC Inc provides Internet-based technology services and solutions to the Chinese language speaking hedge funds, mutual funds, registered investment advisors, proprietary trading groups, and brokerage firms engaging in securities market transactions and settlements globally. It offers complete suite trading solutions, including services such as fund establishment, issuance, custody, transaction, and settlement. The Company currently has two operating segments, Gujia, MM Future, MMBD Advisory and HC Securities, and MM Global. It generates maximum revenue from the Gujia segment. Gujia segment provides market data services and investor relations management services to customers in China.

Share on Social Networks: